Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
1.
J. pediatr. (Rio J.) ; 98(4): 362-368, July-Aug. 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1386115

RESUMO

Abstract Objectives: To detect RSV or other thirteen respiratory viruses as possible causer agent of bronchiolitis in infants. Method: This is an epidemiological analytical study, conducted using a nasopharyngeal aspirate of 173 hospitalized children younger than two years old with severe bronchiolitis in three hospitals in the Campinas Metropolitan Region (CMR) during 2013-14. The data was statically evaluated by Pearson's chi-squared test with statistical significance of 0.05 and 95% confidence level. Results: As expected, the most prevalent viruses detected were RSV A and B in 47% and 16% of the samples, respectively. However, almost a third of severe bronchiolitis cases there were no detection of RSV, and the viruses more commonly detected were rhinoviruses, which were identified in almost a quarter of all positive samples for at least a viral agent. Conclusions: Although nothing could be concluded from the disease severity and clinicalepidemiological data, the present study's results indicate that severe bronchiolitis is not always related to RSV infections in children younger than two years old, and the rhinoviruses were more prevalent in these cases. These findings reinforce the need to carry out a

2.
J Pediatr (Rio J) ; 98(4): 362-368, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34942156

RESUMO

OBJECTIVES: To detect RSV or other thirteen respiratory viruses as possible causer agent of bronchiolitis in infants. METHOD: This is an epidemiological analytical study, conducted using a nasopharyngeal aspirate of 173 hospitalized children younger than two years old with severe bronchiolitis in three hospitals in the Campinas Metropolitan Region (CMR) during 2013-14. The data was statically evaluated by Pearson's chi-squared test with statistical significance of 0.05 and 95% confidence level. RESULTS: As expected, the most prevalent viruses detected were RSV A and B in 47% and 16% of the samples, respectively. However, almost a third of severe bronchiolitis cases there were no detection of RSV, and the viruses more commonly detected were rhinoviruses, which were identified in almost a quarter of all positive samples for at least a viral agent. CONCLUSIONS: Although nothing could be concluded from the disease severity and clinical-epidemiological data, the present study's results indicate that severe bronchiolitis is not always related to RSV infections in children younger than two years old, and the rhinoviruses were more prevalent in these cases. These findings reinforce the need to carry out a viral diagnosis in the hospital emergency would be very appropriate for all cases of respiratory infections in children, even for diseases in which the primary etiological agent seems to be well known.


Assuntos
Bronquiolite Viral , Bronquiolite , Infecções por Vírus Respiratório Sincicial , Infecções Respiratórias , Bronquiolite/diagnóstico , Bronquiolite/epidemiologia , Bronquiolite Viral/epidemiologia , Criança , Pré-Escolar , Humanos , Lactente , Infecções por Vírus Respiratório Sincicial/epidemiologia , Rhinovirus , Índice de Gravidade de Doença
4.
Rev. paul. pediatr ; 34(4): 503-509, Oct.-Dec. 2016. tab, graf
Artigo em Inglês | LILACS | ID: biblio-830739

RESUMO

Abstract Objective: To review the literature addressing the relationship of growth and nutritional parameters with pulmonary function in pediatric patients with cystic fibrosis. Data source: A collection of articles published in the last 15 years in English, Portuguese and Spanish was made by research in electronic databases - PubMed, Cochrane, Medline, Lilacs and Scielo - using the keywords cystic fibrosis, growth, nutrition, pulmonary function in varied combinations. Articles that addressed the long term association of growth and nutritional parameters, with an emphasis on growth, with pulmonary disease in cystic fibrosis, were included, and we excluded those that addressing only the relationship between nutritional parameters and cystic fibrosis and those in which the aim was to describe the disease. Data synthesis: Seven studies were included, with a total of 12,455 patients. Six studies reported relationship between growth parameters and lung function, including one study addressing the association of growth parameters, solely, with lung function, and all the seven studies reported relationship between nutritional parameters and lung function. Conclusions: The review suggests that the severity of the lung disease, determined by spirometry, is associated with body growth and nutritional status in cystic fibrosis. Thus, the intervention in these parameters can lead to the better prognosis and life expectancy for cystic fibrosis patients.


Resumo Objetivo: Revisar a literatura que aborda a relação entre os parâmetros de crescimento e nutricionais com a função pulmonar em pacientes pediátricos com fibrose cística. Fontes de dados: Dados foram coletados de artigos publicados nos últimos 15 anos em Inglês,Português e Espanhol através de pesquisa nas bases de dados eletrônicas - PubMed, Cochrane, Medline, Lilacs e Scielo - usando as palavras-chave: fibrose cística, crescimento, nutrição, função pulmonar utilizando combinações variadas. Os artigos que analisaram a associação de longo prazo entre parâmetros de crescimento e nutricionais, com ênfase em crescimento, com doença pulmonar em fibrose cística, foram incluídos, sendo excluídos aqueles que analisaram apenas a relação entre os parâmetros nutricionais e fibrose cística e aqueles em que o objetivo era descrever a doença. Síntese dos dados: Sete estudos foram incluídos, com um total de 12.455 pacientes. Seis relataram relação entre parâmetros de crescimento e função pulmonar, incluindo um estudo que analisou apenas a associação de parâmetros de crescimento com a função pulmonar, e todos os sete relataram associação entre parâmetros nutricionais e função pulmonar. Conclusões: A revisão sugere que a gravidade da doença pulmonar, determinada por espirometria, está associada com crescimento corporal e o estado nutricional em fibrose cística. Assim, a intervenção nesses parâmetros pode contribuir para um melhor prognóstico e expectativa de vida em pacientes com fibrose cística.


Assuntos
Humanos , Criança , Estado Nutricional , Fibrose Cística/fisiopatologia , Crescimento , Pulmão/fisiopatologia
5.
Rev. paul. pediatr ; 34(3): 271-280, July-Sept. 2016. tab, ilus
Artigo em Inglês | LILACS | ID: lil-794967

RESUMO

OBJECTIVE: To assess the prevalence, spirometry findings and risk factors for asthma in schoolchildren who were very low birth weight infants with and without bronchopulmonary dysplasia. METHODS: Observational and cross-sectional study. The parents and/or tutors answered the International Study of Asthma and Allergies in Childhood questionnaire. The schoolchildren were submitted to the skin prick test and spirometry assessment. RESULTS: 54 schoolchildren who were very low birth weight infants were assessed and 43 met the criteria for spirometry. Age at the assessment (bronchopulmonary dysplasia=9.5±0.85; without bronchopulmonary dysplasia=10.1±0.86 years) and birth weight (bronchopulmonary dysplasia=916.7±251.2; without bronchopulmonary dysplasia=1171.3±190.5g) were lower in the group with bronchopulmonary dysplasia (p<0.05). The prevalence of asthma among very low birth weight infants was 17/54 (31.5%), being 6/18 (33.3%) in the group with bronchopulmonary dysplasia. There was an association between wool blanket use in the first year of life (p=0.026) with the presence of asthma at school age. The skin prick test was positive in 13/17 (76.5%) and 23/37 (62.2%) of patients with and without asthma, respectively. The schoolchildren with asthma had lower z-score values of forced expiratory flow between 25% and 75% of forced vital capacity (n=16;−1.04±1.19) when compared to the group of patients without asthma (n=27;−0.380.93) (p=0.049). There was no difference between the spirometry variables in the groups regarding the presence or absence of bronchopulmonary dysplasia. CONCLUSIONS: Very low birth weight infants with and without bronchopulmonary dysplasia showed a high prevalence of asthma (33.3% and 30.6%, respectively). Pulmonary flow in the small airways was lower in children with asthma.


OBJETIVO: Avaliar prevalência, espirometria e fatores de risco para asma em escolares que foram recém-nascidos de muito baixo peso com e sem displasia broncopulmonar. MÉTODOS: Estudo observacional e transversal. Aplicou-se aos pais e/ou responsáveis o questionário International Study of Asthma and Allergies in Childhood. Foi feito teste cutâneo de hipersensibilidade imediata e espirometria nos escolares. RESULTADOS: Avaliados 54 escolares que foram recém-nascidos de muito baixo peso e 43 preencheram critérios para espirometria. A idade na avaliação (displasia broncopulmonar=9,5±0,85; sem displasia broncopulmonar=10,1±0,86 anos) e o peso de nascimento (displasia broncopulmonar=916,7±251,2; sem displasia broncopulmonar=1.171,3±190,5 g) foram menores no grupo com displasia broncopulmonar (p<0,05). A prevalência de asma entre os recém-nascidos de muito baixo peso foi de 17/54 (31,5%); no grupo com displasia broncopulmonar, de 6/18 (33,3%). Houve associação entre uso de cobertor de lã no primeiro ano de vida (p=0,026) com presença de asma na idade escolar. O teste cutâneo de hipersensibilidade imediata foi positivo em 13/17 (76,5%) e 23/37 (62,2%) nos grupos com e sem asma, respectivamente. Os escolares com asma apresentaram menores valores em z-score do fluxo expiratório forçado entre 25% e 75% da capacidade vital forçada (n=16; −1,04±1,19) comparados com os do grupo de pacientes sem asma (n=27; −0,38±0,93) (p=0,049). Não houve diferença entre as variáveis da espirometria no grupo com relação à presença ou não de displasia broncopulmonar. CONCLUSÕES: Os recém-nascidos de muito baixo peso, com e sem displasia broncopulmonar, apresentaram prevalência elevada de asma (33,3% e 30,6%, respectivamente). Os fluxos pulmonares das pequenas vias aéreas foram menores nos escolares com asma.


Assuntos
Humanos , Masculino , Feminino , Gravidez , Recém-Nascido , Asma/complicações , Displasia Broncopulmonar/complicações , Recém-Nascido de muito Baixo Peso , Nascimento Prematuro , Serviços de Saúde Escolar
6.
Rev Paul Pediatr ; 34(4): 503-509, 2016 Dec.
Artigo em Inglês, Português | MEDLINE | ID: mdl-27181343

RESUMO

OBJECTIVE: To review the literature addressing the relationship of growth and nutritional parameters with pulmonary function in pediatric patients with cystic fibrosis. DATA SOURCE: A collection of articles published in the last 15 years in English, Portuguese and Spanish was made by research in electronic databases - PubMed, Cochrane, Medline, Lilacs and Scielo - using the keywords cystic fibrosis, growth, nutrition, pulmonary function in varied combinations. Articles that addressed the long term association of growth and nutritional parameters, with an emphasis on growth, with pulmonary disease in cystic fibrosis, were included, and we excluded those that addressing only the relationship between nutritional parameters and cystic fibrosis and those in which the aim was to describe the disease. DATA SYNTHESIS: Seven studies were included, with a total of 12,455 patients. Six studies reported relationship between growth parameters and lung function, including one study addressing the association of growth parameters, solely, with lung function, and all the seven studies reported relationship between nutritional parameters and lung function. CONCLUSIONS: The review suggests that the severity of the lung disease, determined by spirometry, is associated with body growth and nutritional status in cystic fibrosis. Thus, the intervention in these parameters can lead to the better prognosis and life expectancy for cystic fibrosis patients.


Assuntos
Fibrose Cística/fisiopatologia , Crescimento , Pulmão/fisiopatologia , Estado Nutricional , Criança , Humanos
7.
Rev Paul Pediatr ; 34(3): 271-80, 2016 Sep.
Artigo em Inglês, Português | MEDLINE | ID: mdl-26987782

RESUMO

OBJECTIVE: to assess the prevalence, spirometry findings and risk factors for asthma in schoolchildren who were very low birth weight infants with and without bronchopulmonary dysplasia. METHODS: Observational and cross-sectional study. The parents and/or tutors answered the International Study of Asthma and Allergies in Childhood questionnaire. The schoolchildren were submitted to the skin prick test and spirometry assessment. RESULTS: 54 schoolchildren who were very low birth weight infants were assessed and 43 met the criteria for spirometry. Age at the assessment (bronchopulmonary dysplasia=9.5±0.85; without bronchopulmonary dysplasia=10.1±0.86 years) and birth weight (bronchopulmonary dysplasia=916.7±251.2; without bronchopulmonary dysplasia=1,171.3±190.5g) were lower in the group with bronchopulmonary dysplasia (p<0.05). The prevalence of asthma among very low birth weight infants was 17/54 (31.5%), being 6/18 (33.3%) in the group with bronchopulmonary dysplasia. There was an association between wool blanket use in the first year of life (p=0.026) with the presence of asthma at school age. The skin prick test was positive in 13/17 (76.5%) and 23/37 (62.2%) of patients with and without asthma, respectively. The schoolchildren with asthma had lower z-score values of forced expiratory flow between 25% and 75% of forced vital capacity (n=16; -1.04±1.19) when compared to the group of patients without asthma (n=27; -0.38±0.93) (p=0.049). There was no difference between the spirometry variables in the groups regarding the presence or absence of bronchopulmonary dysplasia. CONCLUSIONS: Very low birth weight infants with and without bronchopulmonary dysplasia showed a high prevalence of asthma (33.3% and 30.6%, respectively). Pulmonary flow in the small airways was lower in children with asthma.


Assuntos
Asma/complicações , Asma/diagnóstico , Displasia Broncopulmonar/complicações , Asma/epidemiologia , Criança , Estudos Transversais , Feminino , Humanos , Recém-Nascido de muito Baixo Peso , Masculino , Prevalência , Espirometria
8.
Dis Markers ; 2015: 546891, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26063959

RESUMO

INTRODUCTION: The index of ventilatory efficiency (VE/VCO2) obtained by the progressive exercise test has been considered the gold standard in the prognosis of adults with heart failure, but few studies have evaluated this approach in children. OBJECTIVE: To verify the scientific evidence about the VE/VCO2 in pediatric and adolescents patients. METHODS: A systematic literature review was carried out using the key words VE/VCO2, children, and adolescents using the PEDro and PubMed/MedLine databases. Clinical trials published from 1987 to 2014, including children, adolescents, and young adults up to 25 years, addressing the VE/VCO2 index as a method of evaluation, monitoring, and prognosis were considered. RESULTS: Initially, 95 articles were found; 12 were excluded as the title/abstract did not contain the VE/VCO2 index or because they included patients greater than 25 years of age. From the remaining 83, 58 were repeated between the databases. The final sample consisted of 32 studies including healthy children and children with respiratory and other diseases. CONCLUSION: There are few studies involving cardiorespiratory assessment by ventilatory efficiency. The studies highlight the fact that high VE/VCO2 values are associated with a worse prognosis of patients due to the relationship with the decrease in pulmonary perfusion and cardiac output.


Assuntos
Teste de Esforço/métodos , Insuficiência Cardíaca/diagnóstico , Ventilação Pulmonar/fisiologia , Adolescente , Criança , Pré-Escolar , Insuficiência Cardíaca/fisiopatologia , Humanos , Adulto Jovem
9.
BMC Pulm Med ; 15: 63, 2015 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-25985982

RESUMO

BACKGROUND: Exercise has been studied as a prognostic marker for patients with cystic fibrosis (CF), as well as a tool for improving their quality of life and analyzing lung disease. In this context, the aim of the present study was to evaluate and compare variables of lung functioning. Our data included: (i) volumetric capnography (VCAP) parameters: expiratory minute volume (VE), volume of exhaled carbon dioxide (VCO2), VE/VCO2, ratio of dead space to tidal volume (VD/VT), and end-tidal carbon dioxide (PetCO2); (ii) spirometry parameters: forced vital capacity (FVC), percent forced expiratory volume in the first second of the FVC (FEV1%), and FEV1/FVC%; and (iii) cardiorespiratory parameters: heart rate (HR), respiratory rate, oxygen saturation (SpO2), and Borg scale rating at rest and during exercise. The subjects comprised children, adolescents, and young adults aged 6-25 years with CF (CF group [CFG]) and without CF (control group [CG]). METHODS: This was a clinical, prospective, controlled study involving 128 male and female patients (64 with CF) of a university hospital. All patients underwent treadmill exercise tests and provided informed consent after study approval by the institutional ethics committee. Linear regression, Kruskal-Wallis test, and Mann-Whitney test were performed to compare the CFG and CG. The α value was set at 0.05. RESULTS: Patients in the CFG showed significantly different VCAP values and spirometry variables throughout the exercise test. Before, during, and after exercise, several variables were different between the two groups; statistically significant differences were seen in the spirometry parameters, SpO2, HR, VCO2, VE/VCO2, PetCO2, and Borg scale rating. VCAP variables changed at each time point analyzed during the exercise test in both groups. CONCLUSION: VCAP can be used to analyze ventilatory parameters during exercise. All cardiorespiratory, spirometry, and VCAP variables differed between patients in the CFG and CG before, during, and after exercise.


Assuntos
Dióxido de Carbono/análise , Fibrose Cística/fisiopatologia , Consumo de Oxigênio/fisiologia , Ventilação Pulmonar/fisiologia , Capacidade Vital/fisiologia , Adolescente , Capnografia , Estudos de Casos e Controles , Criança , Teste de Esforço , Feminino , Volume Expiratório Forçado/fisiologia , Humanos , Modelos Lineares , Masculino , Adulto Jovem
10.
BMC Infect Dis ; 15: 58, 2015 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-25887416

RESUMO

BACKGROUND: Microbiological characteristics of sepsis and antimicrobial resistance are well studied, although in State University of Campinas, no data has been published yet. METHODS: The main agents related to sepsis and antimicrobial resistance were analyzed. The blood culture records requested from 4,793 hospitalized patients were analyzed. The samples were processed using the Bact/Alert system for agent identification and antimicrobial susceptibility. RESULTS: A total of 1,017 patients met the inclusion criteria for a sepsis diagnosis, with 2,309 samples tested (2.27 samples/patient). There were 489 positive samples (21% positive) isolated from 337 patients (33.13%), but more rigorous criteria excluding potential contaminants resulted in analysis being restricted to 266 patients (315 agents). The prevalent microorganisms were coagulase negative Staphylococcus (CNS) (15.87%), Escherichia coli (13.0%), Staphylococcus aureus (11.7%), Klebsiella pneumoniae (9.8%), Enterobacter sp (9.5%), Acinetobacter baumannii (9.2%), Pseudomonas aeruginosa (5.7%) and Candida sp (5.1%). Examining antimicrobial resistance in the agents revealed that 51% of the S. aureus isolates were methicillin-resistant S. aureus (MRSA) and 80% of the CNS isolates were oxacillin-resistant. For A. baumannii, the ideal profile drugs were ampicillin sulbactam and piperacillin/tazobactam, and for P. aeruginosa, they were piperacillin/tazobactam and ceftazidime. Enterobacteria showed on average 32.5% and 35.7% resistance to beta-lactams and ciprofloxacin, respectively. When all Gram-negative bacteria were considered, the resistance to beta-lactams rose to 40.5%, and the resistance to ciprofloxacin rose to 42.3%. CONCLUSIONS: Eighty percent of the agents identified in blood cultures from patients with sepsis belonged to a group of eight different agents. For empirical treatment, carbapenems and vancomycin unfortunately still remain the best therapeutic choice, except for A. baumannii and P. aeruginosa, for which piperacillin/tazobactan is the best option.


Assuntos
Hospitais Universitários , Sepse/microbiologia , Acinetobacter baumannii/isolamento & purificação , Adulto , Idoso , Criança , Resistência Microbiana a Medicamentos , Enterobacteriaceae/isolamento & purificação , Feminino , Bactérias Gram-Negativas/isolamento & purificação , Hospitais Universitários/estatística & dados numéricos , Humanos , Lactente , Recém-Nascido , Masculino , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Testes de Sensibilidade Microbiana/métodos , Estudos Retrospectivos , Sepse/sangue , Sepse/epidemiologia , Staphylococcus/isolamento & purificação , Staphylococcus aureus/isolamento & purificação
11.
Rev. paul. pediatr ; 33(1): 3-11, Jan-Mar/2015. tab
Artigo em Inglês | LILACS | ID: lil-744700

RESUMO

OBJECTIVE: The aim of this study was to evaluate by clinical and laboratory parameters how cystic fibrosis (CF) affects growth and nutritional status of children who were undergoing CF treatment but did not receive newborn screening. METHODS: A historical cohort study of 52 CF patients younger than 10 years of age were followed in a reference center in Campinas, Southeast Brazil. Anthropometric measurements were abstracted from medical records until March/2010, when neonatal screening program was implemented. Between September/2009 and March/2010, parental height of the 52 CF patients were also measured. RESULTS: Regarding nutritional status, four patients had Z-scores ≤-2 for height/age (H/A) and body mass index/age (BMI/A). The following variables were associated with improved H/A ratio: fewer hospitalizations, longer time from first appointment to diagnosis, longer time from birth to diagnosis and later onset of respiratory disease. Forced vital capacity [FVC(%)], forced expiratory flow between 25-75% of FVC [FEF25-75(%)], forced expiratory volume in the first second [FEV1(%)], gestational age, birth weight and early respiratory symptoms were associated with improved BMI/A. CONCLUSIONS: Greater number of hospitalizations, diagnosis delay and early onset of respiratory disease had a negative impact on growth. Lower spirometric values, lower gestational age, lower birth weight, and early onset of respiratory symptoms had negative impact on nutritional status. Malnutrition was observed in 7.7% of cases, but 23% of children had nutritional risk. .


OBJETIVO: Avaliar por meio de parâmetros clínicos e laboratoriais como a fibrose cística (FC) afeta o crescimento e estado nutricional de crianças submetidas ao tratamento de FC que não foram submetidas à triagem neonatal. MÉTODOS: Uma coorte histórica com 52 pacientes com FC menores de 10 anos foi acompanhada em um centro de referência em Campinas, Sudeste do Brasil. Peso e altura foram coletados de prontuários médicos até março de 2010, quando a triagem neonatal foi implementada. Entre setembro de 2009 a março de 2010 a altura dos pais foi medida. RESULTADOS: Quatro pacientes tiveram escores Z ≤ -2 para altura/idade (A/I) e índice de massa corporal/idade (IMC/A). As seguintes variáveis foram associadas com melhor razão A/I: menor número de hospitalizações, maior tempo entre a primeira consulta e o diagnóstico, maior tempo entre o nascimento e o diagnóstico e início tardio da doença respiratória. Capacidade vital forçada [CVF(%)], fluxo expiratório forçado entre 25-75% da CVF [FEF25-75(%)], volume expiratório forçado no primeiro segundo [VEF1(%)], idade gestacional, peso ao nascer e início dos sintomas respiratórios foram associados com melhor IMC/I. CONCLUSÕES: Maior número de hospitalizações, retardo no diagnóstico e início precoce da doença respiratória tiveram impacto negativo no crescimento. Menores valores espirométricos, menor idade gestacional, menor peso ao nascer e o início precoce dos sintomas respiratórios tiveram impacto negativo no estado nutricional. A desnutrição foi observada em 7,7% dos casos, mas 23% das crianças apresentaram risco nutricional. .


Assuntos
Humanos , Antibacterianos/farmacologia , Antifúngicos/farmacologia , Antineoplásicos/farmacologia , Bactérias/efeitos dos fármacos , Fungos/efeitos dos fármacos , Peptidomiméticos/farmacologia , Antibacterianos/química , Antibacterianos/síntese química , Antifúngicos/química , Antifúngicos/síntese química , Antineoplásicos/química , Antineoplásicos/síntese química , Bactérias/crescimento & desenvolvimento , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Fungos/crescimento & desenvolvimento , Testes de Sensibilidade Microbiana , Estrutura Molecular , Peptídeos/química , Peptidomiméticos/química , Peptidomiméticos/síntese química , Selênio/química , Relação Estrutura-Atividade , Enxofre/química , Telúrio/química
12.
Rev Paul Pediatr ; 33(1): 3-11, 2015.
Artigo em Português | MEDLINE | ID: mdl-25681074

RESUMO

OBJECTIVE: The aim of this study was to evaluate by clinical and laboratory parameters how cystic fibrosis (CF) affects growth and nutritional status of children who were undergoing CF treatment but did not receive newborn screening. METHODS: A historical cohort study of 52 CF patients younger than 10 years of age were followed in a reference center in Campinas, Southeast Brazil. Anthropometric measurements were abstracted from medical records until March/2010, when neonatal screening program was implemented. Between September/2009 and March/2010, parental height of the 52 CF patients were also measured. RESULTS: Regarding nutritional status, four patients had Z-scores ≤ -2 for height/age (H/A) and body mass index/age (BMI/A). The following variables were associated with improved H/A ratio: fewer hospitalizations, longer time from first appointment to diagnosis, longer time from birth to diagnosis and later onset of respiratory disease. Forced vital capacity [FVC(%)], forced expiratory flow between 25-75% of FVC [FEF25-75(%)], forced expiratory volume in the first second [FEV1(%)], gestational age, birth weight and early respiratory symptoms were associated with IMC/A. CONCLUSIONS: Greater number of hospitalizations, diagnosis delay and early onset of respiratory disease had a negative impact on growth. Lower spirometric values, lower gestational age, lower birth weight, and early onset of respiratory symptoms had negative impact on nutritional status. Malnutrition was observed in 7.7% of cases, but 23% of children had nutritional risk.


Assuntos
Fibrose Cística/fisiopatologia , Crescimento , Estado Nutricional , Estatura , Índice de Massa Corporal , Criança , Pré-Escolar , Feminino , Humanos , Recém-Nascido , Masculino , Triagem Neonatal
13.
Dis Markers ; 2015: 306825, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25667564

RESUMO

The gold standard for diagnosing cystic fibrosis (CF) is a sweat chloride value above 60 mEq/L. However, this historical and important tool has limitations; other techniques should be studied, including the nasal potential difference (NPD) test. CFTR gene sequencing can identify CFTR mutations, but this method is time-consuming and too expensive to be used in all CF centers. The present study compared CF patients with two classes I-III CFTR mutations (10 patients) (G1), CF patients with classes IV-VI CFTR mutations (five patients) (G2), and 21 healthy subjects (G3). The CF patients and healthy subjects also underwent the NPD test. A statistical analysis was performed using the Mann-Whitney, Kruskal-Wallis, χ(2), and Fisher's exact tests, α = 0.05. No differences were observed between the CF patients and healthy controls for the PDMax, Δamiloride, and Δchloride + free + amiloride markers from the NPD test. For the finger value, a difference between G2 and G3 was described. The Wilschanski index values were different between G1 and G3. In conclusion, our data showed that NPD is useful for CF diagnosis when classes I-III CFTR mutations are screened. However, if classes IV-VI are considered, the NPD test showed an overlap in values with healthy subjects.


Assuntos
Fibrose Cística/diagnóstico , Eletrodiagnóstico/métodos , Potenciais da Membrana , Mutação , Mucosa Nasal/fisiologia , Adolescente , Adulto , Estudos de Casos e Controles , Criança , Fibrose Cística/genética , Feminino , Humanos , Masculino , Mucosa Nasal/metabolismo
14.
BMC Pulm Med ; 15: 3, 2015 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-25592785

RESUMO

BACKGROUND: In recent years, patients with cystic fibrosis (CF) have tended to experience a longer life expectancy and higher quality of life. In this context, the aim of the present study was to evaluate and compare the demographic, clinical, and laboratory markers of patients with CF during the last two decades at a CF referral center. METHODS: A retrospective study of the demographic, clinical, and laboratory markers for CF treatment at a CF referral center was performed during two decades: 2000 (DI, 1990-2000, n = 104 patients) and 2010 (DII, 2000-2010, n = 181 patients). RESULTS: The following variables were less common in DI than in DII: (i) pancreatic insufficiency, (ii) meconium ileus, (iii) diabetes mellitus, (iv) Burkholderia cepacia colonization, (v) moderate and severe Shwachman-Kulczycki score (SKS), (vi) F508del mutation screening, (vii) patients without an identified CFTR mutation (class IV, V, or VI mutation), (viii) patients above the 10th percentile for weight and height, (ix) restrictive lung disease, and (x) older patients (p < 0.01). The following variables were more common in DI than in DII: (i) excellent and good SKS, (ii) F508del heterozygous status, (iii) colonization by mucoid and nonmucoid Pseudomonas aeruginosa, (iv) obstructive lung disease, and (v) minimal time for CF diagnosis (p < 0.01). CONCLUSION: Clinical outcomes differed between the two decades. Demographic, clinical, and laboratory markers in patients with CF are useful tools and should be encouraged in CF referral centers to determine the results of CF management and treatment, enabling a better understanding of this disease and its clinical evolution. Early diagnosis and management of CF will improve patients' quality of life and life expectancy until personalized drug therapy is possible for all patients with CF.


Assuntos
Biomarcadores/metabolismo , Fibrose Cística/epidemiologia , Previsões , Adolescente , Adulto , Idoso , Brasil/epidemiologia , Criança , Pré-Escolar , Fibrose Cística/diagnóstico , Fibrose Cística/metabolismo , Feminino , Seguimentos , Volume Expiratório Forçado/fisiologia , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Prevalência , Qualidade de Vida , Estudos Retrospectivos , Espirometria , Adulto Jovem
15.
BMC Pulm Med ; 14: 198, 2014 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-25495771

RESUMO

BACKGROUND: The classic sweat test (CST) is the golden standard for cystic fibrosis (CF) diagnosis. Then, our aim was compare the production and volume of sweat, and side effects caused by pulsed direct current (PDC) and constant direct current (CDC). To determine the optimal stimulation time (ST) for the sweat collection. To verify the PDC as CF diagnosis option. METHODS: Prospective study with cross-sectional experimental intervention. Experiment 1 (right arm): PDC and CDC. ST at 10 min and sweat collected at 30 min. Currents of 0.5; 0.75; 1.0 and 1.5 mA and frequencies of 0, 200, 1,000 and 5,000 Hz applied. Experiment 2 (left arm): current of 1.0 mA, ST at 5 and 10 min and sweat collected at 15 and 30 min with frequencies of 0; 200; 1,000 and 5,000 Hz applied Experiments 1 and 2 were performed with current density (CD) from 0.07 to 0.21 mA/cm2. Experiment 3: PDC was used in typical CF patients with two CFTR mutations screened and or with CF diagnosis by rectal biopsy and patients with atypical CF. RESULTS: 48 subjects (79.16% female) with average of 29.54 ± 8.87 years old were enrolled. There was no statistical difference between the interaction of frequency and current in the sweat weight (p = 0.7488). Individually, positive association was achieved between weight sweat and stimulation frequency (p = 0.0088); and current (p = 0.0025). The sweat production was higher for 10 min of stimulation (p = 0.0023). The sweat collection was better for 30 min (p = 0.0019). The skin impedance was not influenced by ST and sweat collection (p > 0.05). The current frequency was inversely associated with the skin impedance (p < 0.0001). The skin temperature measured before stimulation was higher than after (p < 0.0001). In Experiment 3 (29 subjects) the PDC showed better kappa index compared to CDC (0.9218 versus 0.5205, respectively). CONCLUSIONS: The performance of the CST with CDC and PDC with CD of 0.14 to 0.21 mA/cm2 showed efficacy in steps of stimulation and collection of sweat, without side effects. The optimal stimulation time and sweat collection were, respectively, 10 and 30 min.


Assuntos
Fibrose Cística/diagnóstico , Eletrodiagnóstico/métodos , Iontoforese/métodos , Suor/metabolismo , Adulto , Biópsia , Cloretos/análise , Impedância Elétrica , Eletrodiagnóstico/efeitos adversos , Feminino , Humanos , Iontoforese/efeitos adversos , Masculino , Agonistas Muscarínicos/farmacologia , Pilocarpina/farmacologia , Estudos Prospectivos , Reto/patologia , Suor/química , Glândulas Sudoríparas/efeitos dos fármacos , Glândulas Sudoríparas/fisiopatologia , Fatores de Tempo , Adulto Jovem
16.
J. bras. pneumol ; 40(6): 617-625, Nov-Dec/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-732563

RESUMO

OBJECTIVE: To determine, in a sample of infants, the prevalence of and risk factors for occasional wheezing (OW) and recurrent wheezing-wheezy baby syndrome (WBS). METHODS: Parents of infants (12-15 months of age) completed the International Study of Wheezing in Infants questionnaire. RESULTS: We included 1,269 infants residing in the city of Blumenau, Brazil. Of those, 715 (56.34%) had a history of wheezing, which was more common among boys. The prevalences of OW and WBS were 27.03% (n = 343) and 29.31% (n = 372), respectively. On average, the first wheezing episode occurred at 5.55 ± 2.87 months of age. Among the 715 infants with a history of wheezing, the first episode occurred within the first six months of life in 479 (66.99%), and 372 (52.03%) had had three or more episodes. Factors associated with wheezing in general were pneumonia; oral corticosteroid use; a cold; attending daycare; having a parent with asthma or allergies; mother working outside the home; male gender; no breastfeeding; and mold. Factors associated with WBS were a cold; physician-diagnosed asthma; ER visits; corticosteroid use; pneumonia; bronchitis; dyspnea; attending daycare; bronchodilator use; having a parent with asthma; no breastfeeding; mother working outside the home; and a dog in the household. CONCLUSIONS: The prevalence of wheezing in the studied population was high (56.34%). The etiology was multifactorial, and the risk factors were intrinsic and extrinsic (respiratory tract infections, allergies, attending daycare, and early wheezing). The high prevalence and the intrinsic risk factors indicate the need and the opportunity for epidemiological and genetic studies in this population. In addition, mothers should be encouraged to prolong breastfeeding ...


OBJETIVO: Determinar a prevalência e os fatores de risco para sibilância ocasional (SO) e recorrente - síndrome do lactente sibilante (SLS). MÉTODOS: Pais de lactentes (12-15 meses de idade) responderam o questionário escrito Estudio Internacional de Sibilancias en Lactantes. RESULTADOS: Foram incluídos 1.269 lactentes residentes na cidade de Blumenau (SC). Desses, 715 (56,34%) apresentavam sibilância, sendo essa mais frequente nos meninos. As prevalências de SO e SLS foram de 27,03% (n = 343) e 29,31% (n = 372), respectivamente. O primeiro episódio de sibilância ocorreu aos 5,55 ± 2,87 meses de idade em média. Em 479/715 (66,99%) lactentes com sibilância, o primeiro episódio ocorreu nos primeiros seis meses de vida, enquanto 372/715 (52,03%) apresentaram três ou mais episódios. Os fatores associados com sibilância foram pneumonia; uso de corticoide oral; resfriado; frequência a creches; pais com asma e/ou alergia; mãe com emprego; gênero masculino; sem aleitamento materno; e mofo. Os fatores associados com SLS foram resfriado; diagnóstico médico de asma; visitas a serviço de emergência; uso de corticoide oral/inalatório; pneumonia, bronquite; dispneia; frequência a creches; uso de broncodilatador; pais com asma; sem aleitamento materno; mãe com emprego; e presença de cachorro na residência. CONCLUSÕES: A prevalência de sibilância na população estudada foi elevada, sendo multifatorial e com fatores de risco intrínsecos e extrínsecos (infecções do trato respiratório, alergia nos pais, frequência a creches e idade precoce de chiado). A elevada ...


Assuntos
Feminino , Humanos , Lactente , Masculino , Sons Respiratórios/etiologia , Asma/complicações , Brasil/epidemiologia , Estudos Transversais , Prevalência , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença , Fatores Sexuais , Inquéritos e Questionários
17.
Rev Bras Cir Cardiovasc ; 29(2): 266-71, 2014.
Artigo em Inglês, Português | MEDLINE | ID: mdl-25140478

RESUMO

Systematic review of vacuum assisted drainage in cardiopulmonary bypass, demonstrating its advantages and disadvantages, by case reports and evidence about its effects on microcirculation. We conducted a systematic search on the period 1997-2012, in the databases PubMed, Medline, Lilacs and SciELO. Of the 70 selected articles, 26 were included in the review. Although the vacuum assisted drainage has significant potential for complications and requires appropriate technology and professionalism, prevailed in literature reviewed the concept that vacuum assisted drainage contributed in reducing the rate of transfusions, hemodilutions, better operative field, no significant increase in hemolysis, reduced complications surgical, use of lower prime and of smaller diameter cannulas.


Assuntos
Ponte Cardiopulmonar/métodos , Drenagem/métodos , Ponte Cardiopulmonar/efeitos adversos , Drenagem/efeitos adversos , Humanos , Complicações Pós-Operatórias , Reprodutibilidade dos Testes , Medição de Risco , Vácuo
18.
Rev. bras. cir. cardiovasc ; 29(2): 266-271, Apr-Jun/2014. tab
Artigo em Português | LILACS | ID: lil-719423

RESUMO

Revisão sistemática sobre drenagem assistida a vácuo na circulação extracorpórea, demonstrando seus benefícios, desvantagens, por relatos de casos e evidências sobre seus efeitos na microcirculação. Realizou-se pesquisa sistemática, no período de 1997-2012, nas bases de dados do PubMed-Medline, Lilacs e SciELO. Termos: "circulação extracorpórea", "vácuo", "drenagem", "cirurgia cardíaca" e suas correspondentes traduções, em condições variadas. Dos 70 artigos selecionados, 26 foram incluídos na revisão. Embora a drenagem assistida a vácuo possua potencial significante de complicações e exija tecnologia e profissionalismo respectivo adequado, prevaleceu na literatura revisada o conceito de que a drenagem assistida a vácuo contribuiu na redução no índice de transfusões, hemodiluições, melhor campo operatório, não aumento de hemólise significativa, redução de complicações pós-cirúrgicas, uso de menor prime e uso de cânulas de menor calibre.


Systematic review of vacuum assisted drainage in cardiopulmonary bypass, demonstrating its advantages and disadvantages, by case reports and evidence about its effects on microcirculation. We conducted a systematic search on the period 1997-2012, in the databases PubMed, Medline, Lilacs and SciELO. Of the 70 selected articles, 26 were included in the review. Although the vacuum assisted drainage has significant potential for complications and requires appropriate technology and professionalism, prevailed in literature reviewed the concept that vacuum assisted drainage contributed in reducing the rate of transfusions, hemodilutions, better operative field, no significant increase in hemolysis, reduced complications surgical, use of lower prime and of smaller diameter cannulas.


Assuntos
Humanos , Ponte Cardiopulmonar/métodos , Drenagem/métodos , Ponte Cardiopulmonar/efeitos adversos , Drenagem/efeitos adversos , Complicações Pós-Operatórias , Reprodutibilidade dos Testes , Medição de Risco , Vácuo
19.
BMC Med Genet ; 15: 27, 2014 Mar 04.
Artigo em Inglês | MEDLINE | ID: mdl-24593045

RESUMO

BACKGROUND: Cystic fibrosis (CF) clinically manifests with various levels of severity, which are thought to be modulated by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR), modifier genes, and the environment. This study verified whether polymorphisms in modifier genes associated with glutathione (GSH) metabolism influence CF severity. METHODS: A cross-sectional study of 180 CF patients was carried out from 2011 to 2012. We analyzed CFTR mutations, polymorphisms (GSTM1 and GSTT1 deletions, GSTP1 + 313A > G, GCLC-129C > T, and GCLC-3506A > G) in modifier genes and CF clinical severity as assessed by 28 clinical and laboratory variables. RESULTS: Significant associations were found between modifier gene polymorphisms and particular phenotypes or genotype changes. These included GCLC-129C > T with a higher frequency of the Pseudomonas aeruginosa mucoid to CC genotype (p = 0.044), and GCLC-3506A > G with a higher frequency of the no-mucoid P. aeruginosa (NMPA) to AA genotype (p = 0.012). The GSTT1 deletion was associated with a higher frequency of the NMPA to homozygous deletion (p = 0.008), GSTP1 + 313A > G with a minor risk of osteoporosis (p = 0.036), and patient age ≤ 154 months (p = 0.044) with the AA genotype. The Bhalla score was associated with GCLC-3506A > G (p = 0.044) and GSTM1/GSTT1 deletion polymorphisms (p = 0.02), while transcutaneous hemoglobin oxygen saturation levels were associated with GSTT1 deletions (p = 0.048). CONCLUSION: CF severity is associated with polymorphisms in GSH pathways and CFTR mutations.


Assuntos
Fibrose Cística/genética , Glutamato-Cisteína Ligase/genética , Glutationa S-Transferase pi/genética , Glutationa Transferase/genética , Glutationa/metabolismo , Adolescente , Criança , Pré-Escolar , Estudos Transversais , Fibrose Cística/metabolismo , Fibrose Cística/patologia , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Análise Mutacional de DNA , Estudos de Associação Genética , Predisposição Genética para Doença , Haplótipos , Humanos , Lactente , Redes e Vias Metabólicas , Fenótipo , Polimorfismo de Nucleotídeo Único , Deleção de Sequência , Índice de Gravidade de Doença , Adulto Jovem
20.
Allergy Asthma Clin Immunol ; 10(1): 8, 2014 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-24499171

RESUMO

BACKGROUND: Asthma is caused by both environmental and genetic factors. The ADRB2 gene, which encodes the beta 2-adrenergic receptor, is one of the most extensively studied genes with respect to asthma prevalence and severity. The Arg16Gly (+46A > G) and Gln27Glu (+79C > G) polymorphisms in the ADRB2 gene cause changes in the amino acids flanking the receptor ligand site, altering the response to bronchodilators and the risk of asthma through complex pathways. The ADRB2 polymorphisms affect beta-adrenergic bronchodilator action and are a tool to identify at-risk populations. OBJECTIVE: To determine the frequency of these two polymorphisms in allergic asthma patients and healthy subjects and to correlate these data with the occurrence and severity of asthma. METHODS: Eighty-eight allergic asthma patients and 141 healthy subjects were included in this study. The ADRB2 polymorphisms were analyzed using the amplification-refractory mutation system - polymerase chain reaction (ARMS-PCR) technique. The statistical analysis was performed with the SPSS 21.0 software using the Fisher's Exact and χ2 tests. RESULTS: The ADRB2 polymorphisms were associated with asthma occurrence. The Arg16Arg, Gln27Gln and Gln27Glu genotypes were risk factors; the odds ratios were 6.782 (CI = 3.07 to 16.03), 2.120 (CI = 1.22 to 3.71) and 8.096 (CI = 3.90 to 17.77), respectively. For the Gly16Gly and Glu27Glu genotypes, the odds ratios were 0.312 (CI = 0.17 to 0.56) and 0.084 (CI = 0.04 to 0.17), respectively. The haplotype analysis showed that there were associations between the following groups: Arg16Arg-Gln27Gln (OR = 5.108, CI = 1.82 to 16.37), Gly16Gly-Glu27Glu (OR = 2.816, CI = 1.25 to 6.54), Arg16Gly-Gln27Glu (OR = 0.048, CI = 0.01 to 0.14) and Gly16Gly-Gln27Glu (OR = 0.1036, CI = 0.02 to 0.39). The polymorphism Gln27Glu was associated with asthma severity, as the Gln27Gln genotype was a risk factor for severe asthma (OR = 2.798, CI = 1.099 to 6.674) and the Gln27Glu genotype was a protective factor for mild (OR = 3.063, CI = 1.037 to 9.041) and severe (OR = 0.182, CI = 0.048 to 0.691) asthma. CONCLUSIONS: The Arg16Gly and Gln27Glu polymorphisms in the ADRB2 gene are associated with asthma presence and severity.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...